Shares of Nemus Bioscience Inc (OTCMKTS:NMUS – Get Free Report) passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $0.78 and traded as low as $0.72. Nemus Bioscience shares last traded at $0.7701, with a volume of 168,687 shares trading hands.
Nemus Bioscience Price Performance
The company’s 50 day moving average price is $0.78. The stock has a market capitalization of $103.12 million, a PE ratio of -8.56 and a beta of -0.04.
About Nemus Bioscience
Nemus Bioscience, Inc is an early?stage biopharmaceutical company developing proprietary prodrug cannabinoid therapeutics for ophthalmic, dermatological and metabolic diseases. The company leverages synthetic derivatives of naturally occurring cannabinoids, designed to improve bioavailability, tissue targeting and therapeutic efficacy. Nemus operates under an OTCMKTS listing and is headquartered in Houston, Texas.
The company’s pipeline includes multiple preclinical candidates, with lead programs focusing on ophthalmic and dermatological indications.
Further Reading
- Five stocks we like better than Nemus Bioscience
- The Great AI Server Rotation Puts Hewlett Packard Enterprise and Super Micro Computer in Focus
- Generac’s AI Power Pivot Raises a Bigger Question About Data Center Demand
- Medtronic Bottoms, Healthy Rebound Ahead
- GitLab’s Price Recovery Gains Traction—Time to Get On Board?
Receive News & Ratings for Nemus Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nemus Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
